| dc.creator |
Ozaydin, Mehmet |
|
| dc.creator |
ARSLAN, Akif |
|
| dc.creator |
AKSOY, Fatih |
|
| dc.creator |
ARSLAN, Bahriye |
|
| dc.creator |
ERDOGAN, Dogan |
|
| dc.creator |
BAS, Hasan Aydin |
|
| dc.creator |
VAROL, Ercan |
|
| dc.creator |
DOGAN, Abdullah |
|
| dc.date |
2015-12-31T22:00:00Z |
|
| dc.date.accessioned |
2020-10-06T09:39:39Z |
|
| dc.date.available |
2020-10-06T09:39:39Z |
|
| dc.identifier |
32841c15-b034-4c19-a7ec-f40bf217e672 |
|
| dc.identifier |
10.1016/j.medici.2016.02.006 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/32841c15-b034-4c19-a7ec-f40bf217e672/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/56898 |
|
| dc.description |
Background and aim: Atrial fibrillation (AF) is the most common supraventricular arrhythmia following ST-segment elevation myocardial infarction (STEMI). We evaluated the association between use of previous angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers (renin-angiotensin system [RAS] blockers) and started RAS blockers after MI and development of AF in patients presenting with acute STEMI. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction |
|
| dc.type |
info:eu-repo/semantics/article |
|